Cancer Research Articles

Celebrating National Nutrition Month can be healthful and fun. Here are some ideas from the Academy of Nutrition and Dietetics.

Florida Cancer Specialists & Research Institute, LLC (FCS) has appointed Sachin Kamath, MD as Chairman of the FCS Executive Board Compliance Committee, effective February 16, 2023.

Florida Cancer Specialists & Research Institute, LLC (FCS), a consistent top performer among the 126 U.S.-based oncology practices that participated in the Center for Medicare & Medicaid Innovation (CMMI) Oncology Care Model (OCM), shares its results in the payment and delivery model’s final wave which ended in June 2022 in a newly released case study.

A recently published study provides data to support that certain patients can achieve positive outcomes without postoperative radiation.

Research conducted through the Florida Cancer Specialists & Research Institute were featured recently at two global gatherings sponsored by the American Society of Clinical Oncology (ASCO®).

FDA approved the first Non-Covalent (Reversible) BTK inhibitor for the treatment of Relapsed or Refractory Mantle Cell Lymphoma in adult patients.

It’s that time of year again! The time by which 80% of New Year’s Resolutions have failed. What to do if you find yourself in that statistic? Read on!

Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that Hitesh Patel, MD has joined its Executive Board, effective January 27, 2023.